Predicting How a Patient Will Respond to Mesothelioma Treatment
Malignant pleural mesothelioma is a rare cancer. Early diagnosis is challenging. Treatments are the first clinical option in the advanced…
Comparing 3 Standard Treatments for Mesothelioma
There are three standard treatments for malignant pleural mesothelioma. Patients and doctors want to know which is more effective. A…
Diagnosis | Europe | International | Prevention | Prognosis
New Cancer Guidelines to Manage and Treat Mesothelioma
Malignant pleural mesothelioma is a type of cancer that develops from the thin layer of tissue that covers many of…
Dentists Exposed to Asbestos Could Trigger Malignant Mesothelioma
Experts have recommended a new plan to warn dentists exposed to asbestos. Asbestos is a naturally occurring mineral that has been…
Lower Platelet Count Linked to Longer Mesothelioma Survival
A high platelet count may not bode well for people battling malignant pleural mesothelioma. New evidence suggests that survival rates…
The First FDA-Approved Mesothelioma Drug in 15 Years
On October 2, 2020, the first FDA-approved mesothelioma drug in 15 years hit the market. They approved a new combination…
Preventing Malignant Mesothelioma through National Asbestos Regulation
After almost 30 years, one key to preventing malignant mesothelioma is found. A national ban on asbestos in the Netherlands…
Maximizes Your Immune Cell Response with High-Intensity Exercise
There is an increasing role of high-intensity exercise training in cancer care. Evidence suggests that exercise can reduce side effects…
New Drug Targeting Fibrosis may Help Mesothelioma Patients
Targeting fibrosis has therapeutic benefits in mesothelioma. Most drugs have limited effects in difficult-to-treat cancers such as mesothelioma. Often this…
Asbestos Exposure During Childhood Can Lead to Mesothelioma
Scientists are looking at mesothelioma risk in women exposed to asbestos. Asbestos exposure in women varies. But, environmental and domestic…